Spero Therapeutics, Inc. - COM (SPRO)

Historical Portfolio Holders from Q4 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
13.9M
Holdings value Q2 2024
$18M
Value change Q2 2024
+$22.1K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
46
Number of buys Q2 2024
17
Number of sells Q2 2024
-19
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 13.9M $18M +$22.1K $1.30 46
2024 Q1 13.7M $23.6M -$10.7K $1.72 54
2023 Q4 13.3M $19.6M +$232K $1.47 44
2023 Q3 14.2M $17.2M -$231K $1.21 52
2023 Q2 14.4M $20.8M +$16.8K $1.45 55
2023 Q1 14.2M $20.6M -$545K $1.45 46
2022 Q4 14.2M $24.6M -$14.2M $1.73 57
2022 Q3 19.9M $39.7M -$2.5M $2.00 59
2022 Q2 20.7M $15.4M -$13.8M $0.74 58
2022 Q1 20.2M $176M +$3.32M $8.70 97
2021 Q4 19.8M $317M +$1.75M $16.01 83
2021 Q3 18.4M $338M +$16.5M $18.41 87
2021 Q2 16.1M $225M -$17.5M $13.96 83
2021 Q1 17.4M $256M +$11.6M $14.72 87
2020 Q4 19.1M $370M +$23.9M $19.39 87
2020 Q3 16.8M $187M +$55.4M $11.16 77
2020 Q2 11.8M $159M +$5.39M $13.53 78
2020 Q1 10.9M $88.1M +$4.28M $8.08 58
2019 Q4 10.8M $104M +$4.17M $9.61 60
2019 Q3 10.4M $110M -$2.89M $10.60 58
2019 Q2 10.6M $122M +$15.8M $11.51 60
2019 Q1 9.27M $119M +$3.65M $12.81 54
2018 Q4 9.1M $56M -$16.9M $6.15 50
2018 Q3 10.7M $113M +$24.5M $10.51 50
2018 Q2 8.12M $119M +$23.8K $14.67 41
2018 Q1 7.7M $110M -$574K $14.25 34
2017 Q4 7.76M $91.1M +$91M $11.75 35